Taipei Veterans General Hospital Practices Guidelines Radiation Oncology Lung Cancer Version 2010.1.

Slides:



Advertisements
Similar presentations
Treatment.
Advertisements

Advances and Emerging Therapy for Lung Cancer
Pulmonary Stereotactic Ablative Radiotherapy:
A phase I dose escalating study of intensity modulated radiation therapy (IMRT) for the treatment of glioblastoma multiforme (GBM) ( #1008) V. Stieber.
10th Annual Lung Cancer Conference Radiation Oncology
Multidisciplinary approaches on chest tumors Radiation Oncology Case Reports.
Staging. Treatment by Stage For early stage lung cancers, surgery or radiation alone For larger tumors (>4 cm) and N+, chemotherapy should be added.
Radiotherapy in prostate cancer Dr.Mina Tajvidi Radiation oncologist.
Stereotactic Body Radiation Therapy (SBRT): The optimal indication for operable tumors in inoperable patients D.Katsochi 1, S.Kosmidis 1, A.Fotopoulou.
Neoadjuvant Adjuvant Curative Palliative Neoadjuvant Radiation therapy the results of a phase III study from Beijing demonstrated a survival benefit.
Radiotherapy Planning for Esophageal Cancers Parag Sanghvi, MD, MSPH 9/12/07 Esophageal Cancer Tumor Board Part 1.
Prof Ramesh S Bilimagga President AROI Group Medical Director - HCG.
SURGEONS ROLE AND INVOLVEMENT IN SBRT PROGRAM Stephen R. Hazelrigg, M.D. Professor and Chair, Cardiothoracic Surgery Southern Illinois University, School.
Conformal Therapy for Lung Cancer B. Schicker, F.J. Schwab*, U. Götz Institute of Radiotherapy and Radiation Oncology St. Vincenz-Krankenhaus Limburg *Clinic.
Update on 18 F-Fluorodeoxyglucose/Positron Emission Tomography and Positron Emission Tomography/ Computed Tomography Imaging of Squamous Head and Neck.
IMRT for the Treatment of Anal Cancer Kristen O’Donnell, MS3 December 12, 2007.
Thorax / Lung Basic Science Conference 12/21/2005 J.R. Nitzkorski.
1 Non–Small-Cell Lung Cancer Diagnosis and Staging EvaluationPurpose Physical examinationIdentify signs Chest x-rayDetermine position, size, number of.
Sequential vs. concurrent chemoradiotherapy for locally advanced non-small cell carcinoma.
Phase II Trial of Continuous Course Re- irradiation Concurrent with Weekly Cisplatinum and Cetuximab for Recurrent Squamous Cell Carcinoma of The Head.
Definitive chemo-radiotherapy for esophageal cancer; failure pattern and salvage treatments Ryuta Koike, Y. Nishimura, K. Nakamatsu, S. Kanamori, M. Okubo,
Prospective Phase I/II Trial of Carbon Ion Radiotherapy for Locally Advanced Non-small-cell Lung Cancer (NSCLC) Abstract title: CIRT for Locally Advanced.
Learn More At: CyberKnife Radiosurgery in the Treatment of Early and Advanced (Oligo-Metastases) Breast Cancer Sandra Vermeulen,
Radiation Therapy in the Management of Cervical Carcinoma Patrick S Swift, MD Medical Director, Radiation Oncology Alta Bates Comprehensive Cancer Center.
Recent Advances in Head and Neck Cancer Robert I. Haddad, M.D., and Dong M. Shin, M.D. The NEW ENGLAND JOURNAL of MEDICINE N Engl J Med 2008;359:
Image-Guided Adaptive Therapy for the Treatment of Lung Cancer
NSCLC stage IIIA type of chemotherapy ? Swiss tumor board Bern – Dr. Christian Monnerat Département Pluridisciplaire d’Oncologie – Hôpital Neuchâtelois.
Irradiation of stem cell niches in the periventricular and sub granular zones in gbm : A Prospective study Akram K S, Monica I, Deepa J, Kesava R, Fayaz.
Comparison of SIB-IMRT and Conventional Accelerated Hyper-fractionated IMRT With Concurrent Cisplatin and Etoposide for Limited Disease SCLC Baosheng Li.
SWISS TUMOR BOARD Lung Cancer March 26, 2009 Novotel Bern Prof. Dr. Mahmut Ozsahin Lausanne University Medical Center (CHUV), Lausanne.
Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma Marc de Perrot, Ronald Feld, Natasha B Leighl,
Principal Author, MD Second Author, MD PhD Third Author, MSc Institution, City, Country 23 January 2013.
Principles of Radiation Oncology in (advanced stage) NSCLC
BRONCHOIAL TUMOURS.
Conflict of Interest Declaration: Nothing to Disclose Presenter: Sophie Lamoureux Title of Presentation: A Comparison of Stereotactic Body Radiotherapy.
Taipei VGH Practice Guidelines: Oncology Guidelines Index Cancer of Lung Version Table of Content StagingStaging, ManuscriptManuscript Taipei Veterans.
Taipei VGH Practice Guidelines: Oncology Guidelines Index Cancer of Oral Cavity Version Table of Content StagingStaging, Manuscript Taipei Veterans.
Anaplastic thyroid cancer based on ATA guideline for Management of Patients with ATC. Thyroid. 2012;22: R3 이정록.
SARC018: A SARC PILOT MULTICENTER STUDY OF PREOPERATIVE RADIATION AND SURGERY IN PATIENTS WITH HIGH- RISK DESMOID TUMORS Robert S. Benjamin, M.D.
 Multidisciplinary Effort › Surgery › Radiation › Systemic Rx (chemo, “drugs”)
Adjuvant and Neoadjuvant Therapy in Non- Small Cell Lung Cancer Seminars in Oncology 2oo5;32 (suppl 2):S9-S15 Kyung Hee Medical Center Department of Thoracic.
Adjuvant or neoadjuvant chemotherapy in minimal N2 stage IIIA nonsmall cell lung cancer Sofie De Craenea, Veerle Surmonta,b and Jan P. van Meerbeeck Current.
Neoadjuvant chemotherapy in the treatment of NSCLC Department of Thoracic Oncology, University Hospital Ghent, Belgium Current Opinion in Oncology 2007,
Taipei VGH Practice Guidelines: Oncology Guidelines Index Cancer of Cervix Version Table of Content StagingStaging, Manuscript Taipei Veterans General.
Taipei Veterans General Hospital Practices Guidelines Oncology Cervical Cancer Version VGH Survival Data as of YYYY/MM/DD Proofing on 2010/MM/DD.
Taipei Veterans General Hospital Practices Guidelines Oncology Rectal Cancer Version
Taipei Veterans General Hospital Practices Guidelines Oncology Oral Cavity Cancer Version
Emily Tanzler, MD Waseet Vance, MD
Lung SBRT Implementation at the Regional Cancer Centre
Radiotherapy for Non-Small Cell Lung Cancer
Dr. Malhar Patel DNB (Radiation Oncology)
CT and PET imaging in non-small cell lung cancer
Principles of Radiation Oncology in (advanced stage) NSCLC
Nasopharyngeal carcinoma
Intensity modulated radiation therapy for definitive treatment of paraortic relapse in patients with endometrial cancer  Shervin M. Shirvani, MD, Ann.
Results of Definitive Radiotherapy in Anal Canal Carcinoma
Treatment With Continuous, Hyperfractionated, Accelerated Radiotherapy (CHART) For Non-Small Cell Lung Cancer (NSCLC): The Weston Park Hospital Experience.
Image–Guided Radiation Therapy for Non–small Cell Lung Cancer
IMRT delivery of preoperative, high dose radiotherapy to a large volume, with Simultaneous Integrated Boost (SIB) in retroperitoneal sarcomas: The Ottawa.
RTOG 0126 A Phase III Randomized Study of High Dose 3D-CRT/IMRT versus Standard Dose 3D-CRT/IMRT in Patients Treated for Localized Prostate Cancer Bijoy.
Reducing Treatment Time and MUs by using Dynamic Conformal Arc Therapy for SBRT Breath-Hold Patients Timothy Miller, Sebastian Nunez Albermann, Besil Raju,
Proposed Changes to the 7th Edition
Intensity modulated radiation therapy for definitive treatment of paraortic relapse in patients with endometrial cancer  Shervin M. Shirvani, MD, Ann.
Image–Guided Radiation Therapy for Non–small Cell Lung Cancer
Clinical Radiation Oncology NMT232 L 10
The Nuances of Staging Lung cancer Gerard A
Neoadjuvant Adjuvant Curative Palliative
What’s new in stage III lung cancer?
Technical Advances of Radiation Therapy for Thymic Malignancies
Patterns of Failure, Toxicity, and Survival after Extrapleural Pneumonectomy and Hemithoracic Intensity-Modulated Radiation Therapy for Malignant Pleural.
Presentation transcript:

Taipei Veterans General Hospital Practices Guidelines Radiation Oncology Lung Cancer Version

Principles of Radiation Therapy General Principles –For resected tumors with pathologic mediastinal nodal involvement (pN2) and negative surgical margins, adjuvant chemotherapy followed by postoperative radiotherapy is preferred, although the sequencing between radiation and chemotherapy in this setting has not been established. –For tumors with pN2 and positive resection margins, postoperative concurrent chemoradiotherapy is recommended if the patient is medically fit. Radiation therapy should start earlier as local recurrence is the most common failure in this group of patients. (NCCN NSCLC V.II.2010)

Principles of Radiation Therapy General Principles –Conformal radiation therapy ± chemotherapy should be offered to patients with stage I, II, and III NSCLC who are medically inoperable but of reasonable performance status and life expectancy. –In patients receiving radiation therapy or chemoradiation with curative intent, treatment interruptions or dose reductions for manageable acute toxicities (i.e. Grade 3 esophagitis or hematologic toxicities) should be minimized by conformal treatment planning and aggressive supportive care. (NCCN NSCLC V.II.2010)

Principles of Radiation Therapy Radiation Simulation, Planning and Delivery Treatment planning should be performed by CT scans obtained in the treatment position. IV contrast should be used for better target delineation whenever possible, especially in patients with central tumors or with nodal disease. PET-CT is preferable in cases with significant atelectasis. PET-CT can significantly improve the target accuracy. (NCCN NSCLC V.II.2010)

Principles of Radiation Therapy Radiation Simulation, Planning and Delivery In patients who receive induction chemotherapy, attempts should be made to obtain a baseline planning CT prior to induction chemotherapy. If feasible, the initial radiation fields should cover the pre-chemotherapy tumor volume, and the cone-down fields should cover the post-chemotherapy tumor volume. However, in patients with compromised lung function or large initial tumor volume, the post-chemotherapy volume can be used to avoid excessive pulmonary toxicity. (NCCN NSCLC V.II.2010)

Principles of Radiation Therapy Radiation Simulation, Planning and Delivery In general, photon beam energy between 4 to 10 MV is recommended for beams passing through low density lung tissue before entering the tumor. For large mediastinal tumors or tumors attached to chest wall, 15 MV or 18 MV energies can be considered for more optimal dose arrangement. In certain situations where there is a large volume of normal lung being irradiated or where tumors are located close to critical structures, intensity modulated radiotherapy (IMRT) may be considered. (NCCN NSCLC V.II.2010)

Principles of Radiation Therapy Radiation Simulation, Planning and Delivery Acceptable methods of accounting for tumor motion, per guideline, include: 1) Motion-encompassing methods such as slow CT scanning, inhale and exhale breath-hold CT, four-dimensional (4-D) respiration-correlated CT; 2) Respiratory gating methods using an external respiration signal or using internal fiducial markers; 3) Breath-hold methods by deep-inspiration breath-hold, active- breathing control (ABC) device, self breath-hold without respiratory monitoring; 4) Forced shallow breathing with abdominal compression; and 5) Real-time tumor-tracking methods. (NCCN NSCLC V.II.2010)

Principles of Radiation Therapy Dose, Volume, and Normal Tissue Constraints for Conventionally Fractionated Radiation Therapy Postoperative radiation dose should be based on margin status. Lung tolerance to radiation after surgery is remarkably smaller than those with the presence of both lungs. For patients receiving postoperative radiation therapy, more strict DVH parameters should be considered for the lung. The exact limit is unknown for lobectomy cases; mean lung dose should be limited to less than 8.5 Gy in pneumonectomy patients.. (NCCN NSCLC V.II.2010)

Principle of Target volume delineation Gross Target Volume (GTV) delineation –The pulmonary extent of lung tumors should be delineated on pulmonary windows, and the mediastinal extent of tumors should be delineated using mediastinal windows. –The FDG-PET images can help to categorize suspected mediastinal and hilar adenopathy and differentiate between collapsed lung tissue from tumor. However, false-positive PET scans can be caused by inflammation, and a biopsy is recommended if there is any question (Image-Guided Radiotherapy of Lung Cancer James D. Cox, Joe Y. Chang, Ritsuko Komaki)

Principle of Target volume delineation Clinical Target Volume (CTV) delineation –includes the area of subclinical involvement around the GTV. For the lung parenchymal disease, a margin with 8 mm for adenocarcinoma and 6 mm for squamous cell carcinoma is required to cover the gross and microscopic disease with 95% accuracy. –In the absence of radiographic proof of invasion, the CTV of the primary lesion should not extend into the chest wall or mediastinum. –8 mm expansions of involved nodes of the CTV is recommended, but not extend into the major airways or lung, chest wall, or vertebral body without evidence of invasion. (Image-Guided Radiotherapy of Lung Cancer James D. Cox, Joe Y. Chang, Ritsuko Komaki)

Principle of Target volume delineation Clinical Target Volume (CTV) delineation –Regarding CTV of nodal regions, elective nodal irradiation (ENI) remains controversial and should be individualized based on tumor volume, dosimetric parameters of adjacent normal structures, and comorbid conditions. Involved field radiation to high dose without ENI has been shown to allow higher dose radiation with acceptable toxicity and low risk of isolated nodal relapse. –In patients who receive postoperative radiotherapy, CTV should consist of the bronchial stump and high-risk draining lymph node stations. (Image-Guided Radiotherapy of Lung Cancer James D. Cox, Joe Y. Chang, Ritsuko Komaki)

Principle of Target volume delineation Planning Target Volume (PTV) –When patients are immobilized with a Vac-Loc bag or other devices, expansion along all axes of 7 mm is recommended. –When daily image-guided setup is used, the setup uncertainty can be reduced to 5 mm. –For patients with tumor motion of < 5mm, simple expansion for the GTV margin is adequate. –Typically CTV could be expanded 1 cm in all directions (1.5 cm superiorly or inferiorly for tumors of the lower lobe). (Image-Guided Radiotherapy of Lung Cancer James D. Cox, Joe Y. Chang, Ritsuko Komaki)

Principles of Radiation Therapy (from NCCN v2.2010) Dose, Volume, and Normal Tissue Constraints for Conventionally Fractionated Radiation Therapy (NCCN NSCLC V.II.2010)

Principles of Radiation Therapy Dose, Volume, and Normal Tissue Constraints for Conventionally Fractionated Radiation Therapy (NCCN NSCLC V.II.2010)

Principles of Radiation Therapy Preoperative CCRT –Candidate for preoperative CCRT Superior sulcus T3, T4 Potential respectable disease. Clinical N0 or N1. –Radiation dose: Gy at Gy per fraction –Evaluation: the possibility of surgical resection should be evaluated at 4 th -5 th weeks after CCRT –Resectable: surgery should be done at the 6 th weeks after preoperative CCRT Shift to definitive CCRT when: pneumonectomy is the only way to acquire adequate resection; extensive resection is required for N2 disease,

Principles of Radiation Therapy Definitive chemoradiotherapy –Candidate for definitive CCRT inoperable stage IIIA or IIIB with good performance –Radiation dose: Gy or Gy at Gy per fraction [Note] Radiation dose may be one significant factor for overall survival in stage I-II after radiation alone or stage III disease treated with concurrent chemoradiation. When radiation is given concurrently with chemotherapy, a dose up to 74 Gy may be delivered safely, if the dose to normal structures are strictly limited. The role of high dose radiation with concurrent chemotherapy is currently being tested in a phase III randomized trial (RTOG 0617).

Principles of Radiation Therapy Postoperative chemoradiotherapy Candidate for postoperative CCRT Positive or close margins For resected tumors with pathologic mediastinal nodal involvement (pN2) and negative surgical margins, adjuvant chemotherapy followed by postoperative radiotherapy is preferred (the sequencing between radiation and chemotherapy in this setting has not been established.) Individual cases need to be discussed via a multidisciplinary team.

Principles of Radiation Therapy Small cell lung cancer Radiotherapy for limited disease: Radiotherapy should be delivered as either 1.5 Gy bid to a total dose of 45 Gy (category 1), or Gy once daily to Gy. Start with chemotherapy cycle 1 or 2 (category 1) The radiation target volumes should be defined on the CT scan obtained at the time of radiotherapy planning. However, the pre-chemotherapy CT scan should be reviewed to include the originally involved lymph node regions in the treatment fields. (NCCN SCLC V.I.2010)

Principles of Radiation Therapy Small cell lung cancer Radiotherapy for limited disease: Concurrent chemoradiotherapy preferable to sequential therapy in fit patients (category 1) Three-dimensional (3D) conformal radiation techniques are preferred, if available. PCI dose 25 Gy in 10 fractions or 30 Gy in fractions (NCCN SCLC V.I.2010)

Discussion

Principles of Radiation Therapy General Principles –Radiation therapy can be offered as an adjunct for operable patients with resectable diseases, as the primary local treatment for patients with medically inoperable or unresectable diseases, and as an important palliative modality for patients with incurable diseases. –Radiation therapy can be offered to primary or distant sites as palliative care for stage IV patients with extensive metastasis. (NCCN NSCLC V.II.2010)

Principles of Radiation Therapy Dose, Volume, and Normal Tissue Constraints for Conventionally Fractionated Radiation Therapy For treatment volume consideration, PTV should be defined per ICRU- 62 guidelines, based on GTV, plus CTV margin for microscopic diseases, ITV margins for target motion, and margins for daily set-up errors. GTV should be confined to visible tumors (include both primary and nodal diseases) on CT or PET-CT. (NCCN NSCLC V.II.2010)

Principles of Radiation Therapy Radiation Simulation, Planning and Delivery Significantly lower risk of radiation pneumonitis and improved overall survival have been observed with IMRT compared to 3-D conformal radiation therapy for lung cancer When IMRT and proton therapy are used, daily image guidance at delivery should be used for quality assurance. The modality of IGRT should be based on the institutional experience and the treatment accuracy. (NCCN NSCLC V.II.2010)